B.R.A.I.N. Biotechnology Research and Information Network AG

B.R.A.I.N. Biotechnology Research and Information Network AG develops enzymes, biocatalysts, and bioactive natural substances for manufacturers in the chemical and consumer goods industries in Germany, the United States, and France. The company operates through BioScience and BioIndustrial segments. Its portfolio comprises various patented technologies, resources, and solutions, such as EvoSolution, METAGENOME, BRAINzyme, LIL, ABEL, CompActives, and BioCompActives. The company identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and natural-resource substances for product development in the food manufacturing and animal feed industry, cosmetics, and chemical industries; new or optimized enzymes, and biocatalysts that meet complex process and application requirements; and microorganisms as the functional biomass for optimized industrial production processes or to establish bioprocesses in chemical procedures. It also designs and refines multi-step conversion paths for the biosynthesis of chemicals from renewable raw materials. The company has strategic partnership with AnalytiCon Discovery GmbH and Roquette to develop natural sweeteners and sweet taste enhancers. B.R.A.I.N. Biotechnology Research and Information Network AG was founded in 1993 and is based in Zwingenberg, Germany.

Trade B.R.A.I.N. Biotechnology Research and Information Network AG at these brokers
1 2 3 4 5 6 7 8 9 10
3.75
  • Platforms: Andriod App, iOS App, Mobile App, WebTrader
  • License: Not Applicable
Your capital is at risk
1 2 3 4 5 6 7 8 9 10
3.75
  • Platforms: Andriod App, Apple App, iOS App, MetaTrader 4, MetaTrader 5, Mobile App, Proprietary, WebTrader
  • License: CySEC, FCA UK
Your capital is at risk
1 2 3 4 5 6 7 8 9 10
4.5
  • Platforms: Andriod App, Apple App, iOS App, Mobile App, WebTrader
  • License: ASIC, CySEC, FCA UK
Your capital is at risk